SQZ Biotech

OverviewSuggest Edit

SQZ Biotechnologies develops cell therapies that harness the body’s natural immune system to combat disease. The Company primarily focuses on preclinical immuno-therapy programs in oncology and other serious diseases. It develops CellSqueeze, a technology platform for engineering various cell functions for therapeutic applications.

TypePrivate
Founded2013
HQWatertown, US
Websitesqzbiotech.com
Employee Ratings3.7

Latest Updates

Employees (est.) (Oct 2020)104(-6%)
Cybersecurity ratingBMore

Key People/Management at SQZ Biotech

Armon Sharei

Armon Sharei

Chief Executive Officer and Founder
Teri Loxam

Teri Loxam

Chief Financial Officer
Oliver Rosen

Oliver Rosen

Chief Medical Officer
Larry Knopf

Larry Knopf

General Counsel
Alex Balcom

Alex Balcom

Vice President, Finance
Katherine Seidl

Katherine Seidl

Vice President, Immunology
Show more

SQZ Biotech Office Locations

SQZ Biotech has an office in Watertown
Watertown, US (HQ)
200 Arsenal Yards Blvd
Watertown, US
134 Coolidge Ave
Show all (2)

SQZ Biotech Financials and Metrics

Summary Metrics

Founding Date

2013

SQZ Biotech total Funding

$233.4 m

SQZ Biotech latest funding size

$65 m

Time since last funding

5 months ago

SQZ Biotech investors

SQZ Biotech's latest funding round in May 2020 was reported to be $65 m. In total, SQZ Biotech has raised $233.4 m
Show all financial metrics

SQZ Biotech Cybersecurity Score

Cybersecurity ratingPremium dataset

B

81/100

SecurityScorecard logo

SQZ Biotech Online and Social Media Presence

Embed Graph

SQZ Biotech News and Updates

SQZ Biotech Announces Key Executive and Board of Directors Appointments

WATERTOWN, Mass., Sept. 27, 2018 /PRNewswire/ -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment of Volker Herrmann, MD, MBA, as Chief Operating Officer and President and Pushkal Garg, MD, to the ...

SQZ Biotech pulls in funding

Massachusetts-based SQZ Biotech, a preclinical stage biotechnology company, has raised an undisclosed amount of funding. The investor was JDRF T1D Fund.

SQZ Biotech Blogs

Roche puts up $125M to expand SQZ cell therapy pact

The post Roche puts up $125M to expand SQZ cell therapy pact appeared first on SQZ Biotech.

Boston’s SQZ signs cancer drug pact with Roche worth up to $1B

The post Boston’s SQZ signs cancer drug pact with Roche worth up to $1B appeared first on SQZ Biotech.

PDQ for SQZ as Roche sweetens cell therapy partnership for potential $1.375B-plus

The post PDQ for SQZ as Roche sweetens cell therapy partnership for potential $1.375B-plus appeared first on SQZ Biotech.

SQZ, Roche expand deal to jointly develop cancer cell therapies

14 The post SQZ, Roche expand deal to jointly develop cancer cell therapies appeared first on SQZ Biotech.

SQZ Biotech Expands Cell Therapy Partnership with Roche to Develop Antigen Presenting Cells for Immune-Oncology

The post SQZ Biotech Expands Cell Therapy Partnership with Roche to Develop Antigen Presenting Cells for Immune-Oncology appeared first on SQZ Biotech.
Show more

SQZ Biotech Frequently Asked Questions

  • When was SQZ Biotech founded?

    SQZ Biotech was founded in 2013.

  • Who are SQZ Biotech key executives?

    SQZ Biotech's key executives are Armon Sharei, Teri Loxam and Oliver Rosen.

  • How many employees does SQZ Biotech have?

    SQZ Biotech has 104 employees.

  • Who are SQZ Biotech competitors?

    Competitors of SQZ Biotech include PamBio, Metacrine and Fulcrum Therapeutics.

  • Where is SQZ Biotech headquarters?

    SQZ Biotech headquarters is located at 200 Arsenal Yards Blvd, Watertown.

  • Where are SQZ Biotech offices?

    SQZ Biotech has an office in Watertown.

  • How many offices does SQZ Biotech have?

    SQZ Biotech has 2 offices.